The Cooper (FRA:CP60) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CP60 The Cooper Companies Inc FRA:CP60
84 GF Score
Price €62.83
GF Value €88.66
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper FFO per Share?

FFO per Share only applies to REITs.

FRA:CP60
84GF Score
The Cooper Companies Inc FRA:CP60
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is The Cooper (FRA:CP60) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of €62.83 is trading 29.1% below its estimated GF Value™ of €88.66. GuruFocus considers The Cooper to be Modestly Undervalued.

Key valuation signals for FRA:CP60:

  • FFO per Share:
  • GF Value™: €88.66 vs. price of €62.83 (29.1% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the FRA:CP60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
84GF Score

Get the complete analysis for FRA:CP60

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€62.83
Price
€88.66
GF Value